Autonomy Capital (Jersey)’s Ginkgo Bioworks DNA Stock Holding History

Autonomy Capital (Jersey)’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,500	Closed	-$1.3M	–	14
2023 Q2	$1.3M	Buy	17,500 +12,151	+227%	+$719K	1.19%	13
2023 Q1	$285K	Hold	5,349	–	–	0.41%	12
2022 Q4	$362K	Hold	5,349	–	–	0.59%	16
2022 Q3	$668K	Sell	5,349 -8,924	-63%	-$1.06M	0.28%	12
2022 Q2	$1.36M	Buy	14,273 +10,815	+313%	+$1.32M	6.43%	8
2022 Q1	$557K	Buy	+3,458	New	+$673K	1.4%	11

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Autonomy Capital (Jersey)'s DNA Position: Q3 2023 in Review

Autonomy Capital (Jersey) sold out of Ginkgo Bioworks (DNA) in Q3 2023, closing a stake of 17,500 shares — an estimated $1.3M sold.

Autonomy Capital (Jersey) first reported a position in DNA in Q1 2022 and held it in 6 quarters. The position peaked at $1.36M in Q2 2022. 349 funds tracked by Wall St. Rank hold DNA as of Q3 2023.

Autonomy Capital (Jersey) reported no remaining Ginkgo Bioworks position as of Q3 2023 after selling out during the quarter.
Autonomy Capital (Jersey) sold 17,500 Ginkgo Bioworks shares in Q3 2023, an estimated $1.3M.
Autonomy Capital (Jersey) first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 6 quarters.
Autonomy Capital (Jersey)'s Ginkgo Bioworks position peaked at $1.36M in Q2 2022.
349 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2023.

Based on Autonomy Capital (Jersey)'s 13F filing for Q3 2023, filed 28 Nov 2023.